Study summary

The purpose is to see if solifenacin has any effect on bladder wall thickness and urine inflammatory marker measurements after 12 weeks of treatment.

Additional Study Details

Phase
4
Product
N/A
Product
Placebo
solifenacin
Type
Interventional
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment number
547
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for Study of 2 doses of solifenacin succinate in female subjects with Overactive Bladder.? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Barrie, ON, Canada, L4M 7G1
    Completed
    Warszawa, Poland, 02-005
    Completed
    Varba, Bulgaria, 9010
    Completed
    Moscow, Russian Federation, 119435
    Completed
    Sofia, Bulgaria, 1606
    Completed
    Madrid, Spain, 28905
    Completed
    Warszawa, Poland, 01-432
    Completed
    Berlin, Germany, 10115
    Completed
    Linz, Austria, 4020
    Completed
    Rome, Italy, 00133
    Completed
    Varese, Italy, 21100
    Completed
    Haugesund, Norway, 5507
    Withdrawn
    Lomme, France, 59462
    Completed
    Madrid, Spain, 28031
    Completed
    Martin, Slovakia, 036 59
    Completed
    Milan, Italy, 20132
    Completed
    Tonsberg, Norway, 3103
    Completed
    Haifa, Israel, 31096
    Completed
    Toronto, ON, Canada, M4N 3M5
    Completed
    Kocaeli, Turkey, 41380
    Completed
    Yaroslavl', Russian Federation
    Completed
    Saint Peterburg, Russian Federation, 199044
    Completed
    Graz, Austria, A-8036
    Completed
    Hannover, Germany, 30625
    Withdrawn
    Izmir, Turkey, 35100
    Completed
    Kortrijk, Belgium, 8500
    Completed
    Timisoara, Romania, 300376
    Completed
    Stockholm, Sweden, 14186
    Completed
    Madrid, Spain, 28046
    Completed
    Nizhniy Novgorod, Russian Federation, 603018
    Completed
    Budapest, Hungary, 1115
    Withdrawn
    Stockholm, Sweden, 11883
    Withdrawn
    Rome, Italy, 00189
    Completed
    Hradec Kralove, Czech Republic, 500 05
    Completed
    Paris, France, 75970
    Completed
    Marseille, France, 13285
    Completed
    Barcelona, Spain, 08036
    Completed
    Sofia, Bulgaria, 1431
    Completed
    Aachen, Germany, 52074
    Completed
    Moscow, Russian Federation, 115516
    Completed
    Avellino, Italy, 83100
    Completed
    Warszawa, Poland, 02-929
    Completed
    Szeged, Hungary, 6725
    Completed
    New York, New York, United States, 11530
    Completed
    Moscow, Russian Federation, 117997
    Completed
    Brampton, ON, Canada, L6T 4S5
    Completed
    Sherbrooke, QC, Canada, J1H 5N4
    Withdrawn
    Genova, Italy, 16128
    Completed
    Gent, Belgium, 9000
    Completed
    Harrow, United Kingdom, HA1 3JU
    Completed
    Kitchener, ON, Canada, N2N 2B9
    Completed
    Szekesfehervar, Hungary, 8000
    Completed
    Krakow, Poland, 31-530
    Completed
    Moscow, Russian Federation, 105425
    Completed
    Victoria, BC, Canada, V8T 5G1
    Completed
    Arendal, Norway, 4809
    Completed
    London, United Kingdom, W2 2YP
    Completed
    Warszawa, Poland, 00-846
    Completed
    Lund, Sweden, 22185
    Completed
    Ramat Gan, Israel, 52621
    Withdrawn
    Targu Mures, Romania, 540103
    Completed
    Istanbul, Turkey, 34664
    Completed
    Brno, Czech Republic, 625 00
    Completed
    Bydgoszcz, Poland, 85-094
    Completed
    Bardejov, Slovakia, 085 01
    Completed
    Victoria, BC, Canada, V8V 3N1
    Completed
    Petah Tikva, Israel, 49100
    Completed
    Milan, Italy, 20153
    Withdrawn
    Arad, Romania, 310175
    Completed
    Drammen, Norway, 3004
    Completed
    Edegem, Belgium, 2650
    Completed
    Podoli, Czech Republic, 147 00
    Completed
    Brantford, ON, Canada, N3R 4N3
    Completed
    Moscow, Russian Federation, 101000
    Completed
    New York, New York, United States, 12601
    Completed
    London, United Kingdom, SE5 9RS
    Completed
    Ankara, Turkey, 06018
    Completed
    Munich, Germany, 81679
    Completed
    Zilina, Slovakia, 010 01
    Withdrawn
    Media, PA, United States, 19063
    Completed
    West Reading, PA, United States, 19611

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?